In Depth
What a difference a century makes
Pharmacy was getting bad press due to some convictions for supplying cocaine, while there was concern about out of date poisons legislation in the July 1920 edition of the Australasian …
Research roundup
Debbie Rigby takes a look at the latest in research news Interventions Delivered in the Community Pharmacy to Manage Allergic Rhinitis Pharmacists have a valuable role in the management of …
Buying and selling in a pandemic
How is COVID-19 affecting the pharmacy sales market? Natalie Sirianni provides an update on the situation Firstly, I would like to say a big thank you to all pharmacists for …
A history of prosecutions
The way pharmacists have been regulated, the punishments they experienced and the types of offences involved have changed over time. David Newgreen reports on his survey of reported prosecutions of …
Clinical tips: COVID-19
Some pharmacies are almost in lockdown while others are barely acknowledging COVID-19 at all… this inconsistency confuses the public, writes Karalyn Huxhagen SA Health this week announced COVID testing in …
Are you ready for e-prescribing?
No matter how small you are, technology makes you mighty, writes Megan Kazantzis E-prescribing is one of the largest and most significant changes the industry has experienced since the computerisation …
Staff Spotlight: Ethan Kreutzer
We speak with the newly elected 2020/21 NAPSA president 1. How do you feel having been elected as the newest NAPSA president? It is a great honour and privilege to …
Research Roundup
Debbie Rigby takes a look at the latest in research news Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia A systematic review and network meta-analysis of 209 studies explored …
Like a bat out of hell
Things won’t return to the old ‘normal’, so pharmacies have to innovate and be clever to thrive as restrictions lift, say Bruce Annabel and Mal Scrymgeour When the coronavirus potentially …
The aged care dilemma
Medicines are intended to prevent and treat disease and illness. Yet, in many cases, particularly those involving older Australians, medicines may be doing more harm than good As masters of …
Clinical tips: Biologicals and biosimilars
Biosimilars and the pharmacist’s role in their supply remains controversial, writes Carlene McMaugh Biological pharmaceutical products have been a part of the landscape of therapeutics for a number of years …
‘We won’t go back to what we did before.’
AJP speaks to a Melbourne pharmacy professor and a student on how education and placements have been transformed during the COVID-19 pandemic The pandemic has sped up changes which may …